MedTrace Logo

Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer

NCT05950503 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-09-02

No results posted yet for this study

Summary

This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

Conditions

Interventions

RADIATION

Hepatic MRI

The patients will undergo hepatic MRI in pre-established timepoints

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Lisa Salvatore, MD, PhD · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2026-06-07
Completion
2027-06-07

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05950503 on ClinicalTrials.gov